Individual Symptom Reduction and Post-Treatment Severity: Varying Levels of Symptom Amelioration in Response to Prolonged Exposure for Post-Traumatic Stress Disorder

Many patients evince significant post-traumatic stress disorder (PTSD) symptoms after a dose of an evidence-based treatment (EBT) for PTSD. Little research systematically addresses if individual PTSD symptoms are more or less resistant to change through an EBT for PTSD or have greater or lesser post...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychological services 2023-02, Vol.20 (1), p.94-106
Hauptverfasser: Cox, Keith S., Wiener, Danielle, Rauch, Sheila A. M., Tuerk, Peter W., Wangelin, Bethany, Acierno, Ron
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 106
container_issue 1
container_start_page 94
container_title Psychological services
container_volume 20
creator Cox, Keith S.
Wiener, Danielle
Rauch, Sheila A. M.
Tuerk, Peter W.
Wangelin, Bethany
Acierno, Ron
description Many patients evince significant post-traumatic stress disorder (PTSD) symptoms after a dose of an evidence-based treatment (EBT) for PTSD. Little research systematically addresses if individual PTSD symptoms are more or less resistant to change through an EBT for PTSD or have greater or lesser post-treatment severity levels. Two studies within VA medical centers provided data. Study 1 (n = 81) was drawn from a randomized clinical trial of Prolonged Exposure (PE), an EBT for PTSD. Study 2 (n = 225) was drawn from two PTSD specialty clinics employing PE. Symptoms were assessed pre- and post-treatments via semi-structured clinician interview (Study 1) and patient self-report (Studies 1 and 2). Most individual symptoms reduced about the same amount through the course of treatment except for avoidance, which showed greater reductions. High heterogeneity in post-treatment symptom severity was found with troubled sleep and hypervigilance displaying above average levels, and traumatic amnesia, foreshortened future, and flashbacks displaying below average levels. Method of symptom measurement had a modest impact on results, as semi-structured clinical interview results were moderately more differentiated than self-report measures. Results were generally consistent between an efficacy (i.e., extremely high, potentially artificial methodological control) and effectiveness (i.e., relatively more real world) context. Primary limitation is analysis of single items on semi-structured clinician interview and patient self-report scale when psychometric validation studies did not interpret measures this way. Moreover, DSM-IV criteria for PTSD were assessed. EBT augmentation and new treatment development should focus on further reducing both PTSD symptoms in general and on the specific symptoms of troubled sleep and hypervigilance, which persist to a greater degree. Impact Statement Even with the best treatments for PTSD, some individual PTSD symptoms do not reduce enough during treatment and so remain after treatment. Through PE, an evidenced-based treatment, most individual PTSD symptoms reduced about the same amount with avoidance patterns reducing the most. Post-treatment, disturbed sleep, and hypervigilance had the highest levels. Patients and clinicians can use this information in planning treatment, and researchers can use it in developing second-generation PTSD treatments.
doi_str_mv 10.1037/ser0000579
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2614229610</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2612805409</sourcerecordid><originalsourceid>FETCH-LOGICAL-a411t-64c7679a628c7474c37c0acfbe823371670d92cf541ec1e9ff9efdf510f6b453</originalsourceid><addsrcrecordid>eNp9kVtrFDEYhoMotl298QdIwBspjOY0h3hXatXCgsVdxLuQzXwpKTPJmENxf5D_09SewAtzkxCePF94X4ReUfKOEt6_TxBJXW0vn6BDKrlsqBh-PK3nVtCGtq08QEcpXRHCZCfZc3TAhRSU8_YQ_T73o7t2Y9ET3uznJYcZf4OxmOyCx9qP-CKk3Gwj6DyDz3gD1xBd3n_A33XcO3-J1_VmSjjYB8HJDJMLUf91OF-FaQk-Ac4BX8QwBX8JIz77tYRUImAb4v0UXeb6yuBNjpAS_uhSiCPEF-iZ1VOCl3f7Cm0_nW1PvzTrr5_PT0_WjRaU5qYTpu96qTs2mF70wvDeEG3sDgbGeU-7noySGVtjAUNBWivBjralxHY70fIVenurXWL4WSBlNbtkYJq0h1CSYh0VrGZYU1-hN_-gV6FEXz-n2MCkGKgkw3-pjrKBtILISh3fUiaGlCJYtUQ313QVJeqmYfXYcIVf3ynLbobxAb2v9NGmF62WtDc61kQnSKbEWBu8kSlWxUoK_gc0o7Lm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2612805409</pqid></control><display><type>article</type><title>Individual Symptom Reduction and Post-Treatment Severity: Varying Levels of Symptom Amelioration in Response to Prolonged Exposure for Post-Traumatic Stress Disorder</title><source>MEDLINE</source><source>EBSCOhost APA PsycARTICLES</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><creator>Cox, Keith S. ; Wiener, Danielle ; Rauch, Sheila A. M. ; Tuerk, Peter W. ; Wangelin, Bethany ; Acierno, Ron</creator><contributor>Kearney, Lisa K</contributor><creatorcontrib>Cox, Keith S. ; Wiener, Danielle ; Rauch, Sheila A. M. ; Tuerk, Peter W. ; Wangelin, Bethany ; Acierno, Ron ; Kearney, Lisa K</creatorcontrib><description>Many patients evince significant post-traumatic stress disorder (PTSD) symptoms after a dose of an evidence-based treatment (EBT) for PTSD. Little research systematically addresses if individual PTSD symptoms are more or less resistant to change through an EBT for PTSD or have greater or lesser post-treatment severity levels. Two studies within VA medical centers provided data. Study 1 (n = 81) was drawn from a randomized clinical trial of Prolonged Exposure (PE), an EBT for PTSD. Study 2 (n = 225) was drawn from two PTSD specialty clinics employing PE. Symptoms were assessed pre- and post-treatments via semi-structured clinician interview (Study 1) and patient self-report (Studies 1 and 2). Most individual symptoms reduced about the same amount through the course of treatment except for avoidance, which showed greater reductions. High heterogeneity in post-treatment symptom severity was found with troubled sleep and hypervigilance displaying above average levels, and traumatic amnesia, foreshortened future, and flashbacks displaying below average levels. Method of symptom measurement had a modest impact on results, as semi-structured clinical interview results were moderately more differentiated than self-report measures. Results were generally consistent between an efficacy (i.e., extremely high, potentially artificial methodological control) and effectiveness (i.e., relatively more real world) context. Primary limitation is analysis of single items on semi-structured clinician interview and patient self-report scale when psychometric validation studies did not interpret measures this way. Moreover, DSM-IV criteria for PTSD were assessed. EBT augmentation and new treatment development should focus on further reducing both PTSD symptoms in general and on the specific symptoms of troubled sleep and hypervigilance, which persist to a greater degree. Impact Statement Even with the best treatments for PTSD, some individual PTSD symptoms do not reduce enough during treatment and so remain after treatment. Through PE, an evidenced-based treatment, most individual PTSD symptoms reduced about the same amount with avoidance patterns reducing the most. Post-treatment, disturbed sleep, and hypervigilance had the highest levels. Patients and clinicians can use this information in planning treatment, and researchers can use it in developing second-generation PTSD treatments.</description><identifier>ISSN: 1541-1559</identifier><identifier>EISSN: 1939-148X</identifier><identifier>DOI: 10.1037/ser0000579</identifier><identifier>PMID: 34941335</identifier><language>eng</language><publisher>United States: Educational Publishing Foundation</publisher><subject>Amnesia ; Anxiety ; Averages ; Avoidance behavior ; Clinical interviews ; Clinical research ; Clinical trials ; Clinicians ; Efficacy ; Evidence based research ; Evidence-based medicine ; Female ; Health Facilities ; Human ; Humans ; Male ; Measurement ; Military Veterans ; Outpatient ; Post traumatic stress disorder ; Posttraumatic Stress Disorder ; Prolonged Exposure Therapy ; Self Report ; Severity ; Severity (Disorders) ; Sleep Treatment ; Stress Disorders, Post-Traumatic - diagnosis ; Stress Disorders, Post-Traumatic - therapy ; Symptoms ; Validation studies ; Vigilance</subject><ispartof>Psychological services, 2023-02, Vol.20 (1), p.94-106</ispartof><rights>2021 American Psychological Association</rights><rights>2021, American Psychological Association</rights><rights>Copyright American Psychological Association Feb 2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a411t-64c7679a628c7474c37c0acfbe823371670d92cf541ec1e9ff9efdf510f6b453</citedby><orcidid>0000-0002-4531-8421 ; 0000-0001-9686-4011</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,30999</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34941335$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Kearney, Lisa K</contributor><creatorcontrib>Cox, Keith S.</creatorcontrib><creatorcontrib>Wiener, Danielle</creatorcontrib><creatorcontrib>Rauch, Sheila A. M.</creatorcontrib><creatorcontrib>Tuerk, Peter W.</creatorcontrib><creatorcontrib>Wangelin, Bethany</creatorcontrib><creatorcontrib>Acierno, Ron</creatorcontrib><title>Individual Symptom Reduction and Post-Treatment Severity: Varying Levels of Symptom Amelioration in Response to Prolonged Exposure for Post-Traumatic Stress Disorder</title><title>Psychological services</title><addtitle>Psychol Serv</addtitle><description>Many patients evince significant post-traumatic stress disorder (PTSD) symptoms after a dose of an evidence-based treatment (EBT) for PTSD. Little research systematically addresses if individual PTSD symptoms are more or less resistant to change through an EBT for PTSD or have greater or lesser post-treatment severity levels. Two studies within VA medical centers provided data. Study 1 (n = 81) was drawn from a randomized clinical trial of Prolonged Exposure (PE), an EBT for PTSD. Study 2 (n = 225) was drawn from two PTSD specialty clinics employing PE. Symptoms were assessed pre- and post-treatments via semi-structured clinician interview (Study 1) and patient self-report (Studies 1 and 2). Most individual symptoms reduced about the same amount through the course of treatment except for avoidance, which showed greater reductions. High heterogeneity in post-treatment symptom severity was found with troubled sleep and hypervigilance displaying above average levels, and traumatic amnesia, foreshortened future, and flashbacks displaying below average levels. Method of symptom measurement had a modest impact on results, as semi-structured clinical interview results were moderately more differentiated than self-report measures. Results were generally consistent between an efficacy (i.e., extremely high, potentially artificial methodological control) and effectiveness (i.e., relatively more real world) context. Primary limitation is analysis of single items on semi-structured clinician interview and patient self-report scale when psychometric validation studies did not interpret measures this way. Moreover, DSM-IV criteria for PTSD were assessed. EBT augmentation and new treatment development should focus on further reducing both PTSD symptoms in general and on the specific symptoms of troubled sleep and hypervigilance, which persist to a greater degree. Impact Statement Even with the best treatments for PTSD, some individual PTSD symptoms do not reduce enough during treatment and so remain after treatment. Through PE, an evidenced-based treatment, most individual PTSD symptoms reduced about the same amount with avoidance patterns reducing the most. Post-treatment, disturbed sleep, and hypervigilance had the highest levels. Patients and clinicians can use this information in planning treatment, and researchers can use it in developing second-generation PTSD treatments.</description><subject>Amnesia</subject><subject>Anxiety</subject><subject>Averages</subject><subject>Avoidance behavior</subject><subject>Clinical interviews</subject><subject>Clinical research</subject><subject>Clinical trials</subject><subject>Clinicians</subject><subject>Efficacy</subject><subject>Evidence based research</subject><subject>Evidence-based medicine</subject><subject>Female</subject><subject>Health Facilities</subject><subject>Human</subject><subject>Humans</subject><subject>Male</subject><subject>Measurement</subject><subject>Military Veterans</subject><subject>Outpatient</subject><subject>Post traumatic stress disorder</subject><subject>Posttraumatic Stress Disorder</subject><subject>Prolonged Exposure Therapy</subject><subject>Self Report</subject><subject>Severity</subject><subject>Severity (Disorders)</subject><subject>Sleep Treatment</subject><subject>Stress Disorders, Post-Traumatic - diagnosis</subject><subject>Stress Disorders, Post-Traumatic - therapy</subject><subject>Symptoms</subject><subject>Validation studies</subject><subject>Vigilance</subject><issn>1541-1559</issn><issn>1939-148X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNp9kVtrFDEYhoMotl298QdIwBspjOY0h3hXatXCgsVdxLuQzXwpKTPJmENxf5D_09SewAtzkxCePF94X4ReUfKOEt6_TxBJXW0vn6BDKrlsqBh-PK3nVtCGtq08QEcpXRHCZCfZc3TAhRSU8_YQ_T73o7t2Y9ET3uznJYcZf4OxmOyCx9qP-CKk3Gwj6DyDz3gD1xBd3n_A33XcO3-J1_VmSjjYB8HJDJMLUf91OF-FaQk-Ac4BX8QwBX8JIz77tYRUImAb4v0UXeb6yuBNjpAS_uhSiCPEF-iZ1VOCl3f7Cm0_nW1PvzTrr5_PT0_WjRaU5qYTpu96qTs2mF70wvDeEG3sDgbGeU-7noySGVtjAUNBWivBjralxHY70fIVenurXWL4WSBlNbtkYJq0h1CSYh0VrGZYU1-hN_-gV6FEXz-n2MCkGKgkw3-pjrKBtILISh3fUiaGlCJYtUQ313QVJeqmYfXYcIVf3ynLbobxAb2v9NGmF62WtDc61kQnSKbEWBu8kSlWxUoK_gc0o7Lm</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Cox, Keith S.</creator><creator>Wiener, Danielle</creator><creator>Rauch, Sheila A. M.</creator><creator>Tuerk, Peter W.</creator><creator>Wangelin, Bethany</creator><creator>Acierno, Ron</creator><general>Educational Publishing Foundation</general><general>American Psychological Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7RZ</scope><scope>PSYQQ</scope><scope>7QJ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4531-8421</orcidid><orcidid>https://orcid.org/0000-0001-9686-4011</orcidid></search><sort><creationdate>20230201</creationdate><title>Individual Symptom Reduction and Post-Treatment Severity: Varying Levels of Symptom Amelioration in Response to Prolonged Exposure for Post-Traumatic Stress Disorder</title><author>Cox, Keith S. ; Wiener, Danielle ; Rauch, Sheila A. M. ; Tuerk, Peter W. ; Wangelin, Bethany ; Acierno, Ron</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a411t-64c7679a628c7474c37c0acfbe823371670d92cf541ec1e9ff9efdf510f6b453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Amnesia</topic><topic>Anxiety</topic><topic>Averages</topic><topic>Avoidance behavior</topic><topic>Clinical interviews</topic><topic>Clinical research</topic><topic>Clinical trials</topic><topic>Clinicians</topic><topic>Efficacy</topic><topic>Evidence based research</topic><topic>Evidence-based medicine</topic><topic>Female</topic><topic>Health Facilities</topic><topic>Human</topic><topic>Humans</topic><topic>Male</topic><topic>Measurement</topic><topic>Military Veterans</topic><topic>Outpatient</topic><topic>Post traumatic stress disorder</topic><topic>Posttraumatic Stress Disorder</topic><topic>Prolonged Exposure Therapy</topic><topic>Self Report</topic><topic>Severity</topic><topic>Severity (Disorders)</topic><topic>Sleep Treatment</topic><topic>Stress Disorders, Post-Traumatic - diagnosis</topic><topic>Stress Disorders, Post-Traumatic - therapy</topic><topic>Symptoms</topic><topic>Validation studies</topic><topic>Vigilance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cox, Keith S.</creatorcontrib><creatorcontrib>Wiener, Danielle</creatorcontrib><creatorcontrib>Rauch, Sheila A. M.</creatorcontrib><creatorcontrib>Tuerk, Peter W.</creatorcontrib><creatorcontrib>Wangelin, Bethany</creatorcontrib><creatorcontrib>Acierno, Ron</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>APA PsycArticles®</collection><collection>ProQuest One Psychology</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>MEDLINE - Academic</collection><jtitle>Psychological services</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cox, Keith S.</au><au>Wiener, Danielle</au><au>Rauch, Sheila A. M.</au><au>Tuerk, Peter W.</au><au>Wangelin, Bethany</au><au>Acierno, Ron</au><au>Kearney, Lisa K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Individual Symptom Reduction and Post-Treatment Severity: Varying Levels of Symptom Amelioration in Response to Prolonged Exposure for Post-Traumatic Stress Disorder</atitle><jtitle>Psychological services</jtitle><addtitle>Psychol Serv</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>20</volume><issue>1</issue><spage>94</spage><epage>106</epage><pages>94-106</pages><issn>1541-1559</issn><eissn>1939-148X</eissn><abstract>Many patients evince significant post-traumatic stress disorder (PTSD) symptoms after a dose of an evidence-based treatment (EBT) for PTSD. Little research systematically addresses if individual PTSD symptoms are more or less resistant to change through an EBT for PTSD or have greater or lesser post-treatment severity levels. Two studies within VA medical centers provided data. Study 1 (n = 81) was drawn from a randomized clinical trial of Prolonged Exposure (PE), an EBT for PTSD. Study 2 (n = 225) was drawn from two PTSD specialty clinics employing PE. Symptoms were assessed pre- and post-treatments via semi-structured clinician interview (Study 1) and patient self-report (Studies 1 and 2). Most individual symptoms reduced about the same amount through the course of treatment except for avoidance, which showed greater reductions. High heterogeneity in post-treatment symptom severity was found with troubled sleep and hypervigilance displaying above average levels, and traumatic amnesia, foreshortened future, and flashbacks displaying below average levels. Method of symptom measurement had a modest impact on results, as semi-structured clinical interview results were moderately more differentiated than self-report measures. Results were generally consistent between an efficacy (i.e., extremely high, potentially artificial methodological control) and effectiveness (i.e., relatively more real world) context. Primary limitation is analysis of single items on semi-structured clinician interview and patient self-report scale when psychometric validation studies did not interpret measures this way. Moreover, DSM-IV criteria for PTSD were assessed. EBT augmentation and new treatment development should focus on further reducing both PTSD symptoms in general and on the specific symptoms of troubled sleep and hypervigilance, which persist to a greater degree. Impact Statement Even with the best treatments for PTSD, some individual PTSD symptoms do not reduce enough during treatment and so remain after treatment. Through PE, an evidenced-based treatment, most individual PTSD symptoms reduced about the same amount with avoidance patterns reducing the most. Post-treatment, disturbed sleep, and hypervigilance had the highest levels. Patients and clinicians can use this information in planning treatment, and researchers can use it in developing second-generation PTSD treatments.</abstract><cop>United States</cop><pub>Educational Publishing Foundation</pub><pmid>34941335</pmid><doi>10.1037/ser0000579</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-4531-8421</orcidid><orcidid>https://orcid.org/0000-0001-9686-4011</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1541-1559
ispartof Psychological services, 2023-02, Vol.20 (1), p.94-106
issn 1541-1559
1939-148X
language eng
recordid cdi_proquest_miscellaneous_2614229610
source MEDLINE; EBSCOhost APA PsycARTICLES; Applied Social Sciences Index & Abstracts (ASSIA)
subjects Amnesia
Anxiety
Averages
Avoidance behavior
Clinical interviews
Clinical research
Clinical trials
Clinicians
Efficacy
Evidence based research
Evidence-based medicine
Female
Health Facilities
Human
Humans
Male
Measurement
Military Veterans
Outpatient
Post traumatic stress disorder
Posttraumatic Stress Disorder
Prolonged Exposure Therapy
Self Report
Severity
Severity (Disorders)
Sleep Treatment
Stress Disorders, Post-Traumatic - diagnosis
Stress Disorders, Post-Traumatic - therapy
Symptoms
Validation studies
Vigilance
title Individual Symptom Reduction and Post-Treatment Severity: Varying Levels of Symptom Amelioration in Response to Prolonged Exposure for Post-Traumatic Stress Disorder
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A06%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Individual%20Symptom%20Reduction%20and%20Post-Treatment%20Severity:%20Varying%20Levels%20of%20Symptom%20Amelioration%20in%20Response%20to%20Prolonged%20Exposure%20for%20Post-Traumatic%20Stress%20Disorder&rft.jtitle=Psychological%20services&rft.au=Cox,%20Keith%20S.&rft.date=2023-02-01&rft.volume=20&rft.issue=1&rft.spage=94&rft.epage=106&rft.pages=94-106&rft.issn=1541-1559&rft.eissn=1939-148X&rft_id=info:doi/10.1037/ser0000579&rft_dat=%3Cproquest_cross%3E2612805409%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2612805409&rft_id=info:pmid/34941335&rfr_iscdi=true